1.00 (-%)
As of Nov 21, 2024
Source:
Lucid Diagnostics, Inc. (Lucid) is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). References in this Form 10-K to we, us and our are to Lucid and, unless the context otherwise requires, its subsidiaries.
Country | United States |
Headquarters | new york, new york |
Phone Number | 212 949 4319 |
Industry | |
CEO | Lishan Aklog, M.D. |
Website | luciddx.com |